Reading Annual report last nifht, which reconfirms all trial timelines. So by 30th Jund 2019, Immuron will have published trial data on ASH, Pediatric NASH, Cdiff. Then with 3x NASH trial data will partner/commercialise NASH. So could be trading anything between $1-$3 or Nasdaq $IMRN equivalent of $30-$90.
- Forums
- ASX - By Stock
- 30th June 2019
Reading Annual report last nifht, which reconfirms all trial...
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.11M |
Open | High | Low | Value | Volume |
9.8¢ | 9.8¢ | 9.7¢ | $4.647K | 47.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29595 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 27873 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29595 | 0.096 |
2 | 38735 | 0.095 |
1 | 22432 | 0.094 |
1 | 40000 | 0.093 |
1 | 80000 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 27873 | 3 |
0.100 | 171349 | 4 |
0.105 | 155642 | 6 |
0.110 | 139728 | 2 |
0.115 | 66632 | 2 |
Last trade - 12.01pm 24/07/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online